424 related articles for article (PubMed ID: 30928673)
1. Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases.
Zhao Y; Hasse S; Zhao C; Bourgoin SG
Biochem Pharmacol; 2019 Jun; 164():74-81. PubMed ID: 30928673
[TBL] [Abstract][Full Text] [Related]
2. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
Tabuchi S
Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
[TBL] [Abstract][Full Text] [Related]
3. Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.
Alioli C; Demesmay L; Peyruchaud O; Machuca-Gayet I
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408784
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
Federico L; Pamuklar Z; Smyth SS; Morris AJ
Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafish.
Yukiura H; Hama K; Nakanaga K; Tanaka M; Asaoka Y; Okudaira S; Arima N; Inoue A; Hashimoto T; Arai H; Kawahara A; Nishina H; Aoki J
J Biol Chem; 2011 Dec; 286(51):43972-43983. PubMed ID: 21971049
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.
D'Souza K; Paramel GV; Kienesberger PC
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570618
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin and LPA receptor signaling in cancer.
Houben AJ; Moolenaar WH
Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
[TBL] [Abstract][Full Text] [Related]
8. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
[TBL] [Abstract][Full Text] [Related]
9. The atherogenic actions of LPC on vascular smooth muscle cells and its LPA receptor mediated mechanism.
Bao L; Qi J; Wang YW; Xi Q; Tserennadmid T; Zhao PF; Qi J; Damirin A
Biochem Biophys Res Commun; 2018 Sep; 503(3):1911-1918. PubMed ID: 30064908
[TBL] [Abstract][Full Text] [Related]
10. Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.
Park SJ; Jun YJ; Lee KJ; Hwang SM; Kim TH; Lee SH; Lee SH
Am J Rhinol Allergy; 2014; 28(3):199-207. PubMed ID: 24980231
[TBL] [Abstract][Full Text] [Related]
11. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
Okudaira S; Yukiura H; Aoki J
Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
[TBL] [Abstract][Full Text] [Related]
12. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
Ryu JM; Han HJ
Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
[TBL] [Abstract][Full Text] [Related]
13. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
Yang F; Chen GX
World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
[TBL] [Abstract][Full Text] [Related]
14. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
Orosa B; García S; Conde C
Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
[TBL] [Abstract][Full Text] [Related]
15. Signalling by lysophosphatidate and its health implications.
Hemmings DG; Brindley DN
Essays Biochem; 2020 Sep; 64(3):547-563. PubMed ID: 32451553
[TBL] [Abstract][Full Text] [Related]
16. Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.
Gotoh M; Fujiwara Y; Yue J; Liu J; Lee S; Fells J; Uchiyama A; Murakami-Murofushi K; Kennel S; Wall J; Patil R; Gupte R; Balazs L; Miller DD; Tigyi GJ
Biochem Soc Trans; 2012 Feb; 40(1):31-6. PubMed ID: 22260662
[TBL] [Abstract][Full Text] [Related]
17. New insights into the autotaxin/LPA axis in cancer development and metastasis.
Leblanc R; Peyruchaud O
Exp Cell Res; 2015 May; 333(2):183-189. PubMed ID: 25460336
[TBL] [Abstract][Full Text] [Related]
18. A defective lysophosphatidic acid-autophagy axis increases miscarriage risk by restricting decidual macrophage residence.
Yang HL; Lai ZZ; Shi JW; Zhou WJ; Mei J; Ye JF; Zhang T; Wang J; Zhao JY; Li DJ; Li MQ
Autophagy; 2022 Oct; 18(10):2459-2480. PubMed ID: 35220880
[TBL] [Abstract][Full Text] [Related]
19. Exosomes bind to autotaxin and act as a physiological delivery mechanism to stimulate LPA receptor signalling in cells.
Jethwa SA; Leah EJ; Zhang Q; Bright NA; Oxley D; Bootman MD; Rudge SA; Wakelam MJ
J Cell Sci; 2016 Oct; 129(20):3948-3957. PubMed ID: 27557622
[TBL] [Abstract][Full Text] [Related]
20. ATX-LPA1 axis contributes to proliferation of chondrocytes by regulating fibronectin assembly leading to proper cartilage formation.
Nishioka T; Arima N; Kano K; Hama K; Itai E; Yukiura H; Kise R; Inoue A; Kim SH; Solnica-Krezel L; Moolenaar WH; Chun J; Aoki J
Sci Rep; 2016 Mar; 6():23433. PubMed ID: 27005960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]